4 results
10-K
2023 FY
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
2023 | 2022 | |||||||
For the Years Ended | ||||||||
December 31, | ||||||||
2023 | 2022 | |||||||
Net revenues | $ | 5,515,144 | $ | 5,617,706 | ||||
Cost of services | 4,103,244 | 4,555,924 | ||||||
Gross profit | 1,411,900 | 1,061,782 | ||||||
Operating expenses: | ||||||||
Salaries and benefits | 2,292,295 | 1,524,971 | ||||||
Professional services | 586,463 | 1,035,902 | ||||||
Research and development expenses | 240,048 | - | ||||||
Selling, general and administrative expenses | 1,131,922 | 575,755 | ||||||
Depreciation | 48,771 | 14,849 | ||||||
Total operating expenses | 4,299,499 | 3,151,477 | ||||||
Operating loss | (2,887,599) | (2,089,695) | ||||||
Other income (expense): | ||||||||
Interest income | 2,942 | 63 | ||||||
Interest expense | (53,686) | (28,533) | ||||||
Total other income (expense) | (50,744) | (28,470) | ||||||
Net loss | $ | (2,938,343) | $ | (2,118,165) | ||||
Weighted average common shares outstanding – basic and diluted | 4,877,861 | 3,041,085 | ||||||
Net loss per common share – basic and diluted | $ | (0.60) | $ | (0.70) |
10-K
2023 FY
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
For the Year | For the Year | |||||||||||
Ended | Ended | |||||||||||
December 31, | December 31, | Increase / | ||||||||||
2023 | 2022 | (Decrease) | ||||||||||
Net revenues | ||||||||||||
Healthcare workforce | $ | 4,259,292 | $ | 5,260,370 | $ | (1,001,078) | ||||||
Population health | 715,499 | 318,036 | 397,463 | |||||||||
Digital health | 515,250 | - | 515,250 | |||||||||
Behavioral and mental health | 12,797 | - | 12,797 | |||||||||
Health education | 12,306 | 39,300 | (26,994) | |||||||||
Net revenues | 5,515,144 | 5,617,706 | (102,562) | |||||||||
Cost of services | 4,103,244 | 4,555,924 | (452,680) | |||||||||
Gross profit | 1,411,900 | 1,061,782 | 350,118 | |||||||||
Operating expenses: | ||||||||||||
Salaries and benefits | 2,292,295 | 1,524,971 | 767,324 | |||||||||
Professional fees | 586,463 | 1,035,902 | (449,439) | |||||||||
Research and development expenses | 240,048 | - | 240,048 | |||||||||
Selling, general and administrative expenses | 1,131,922 | 575,755 | 556,167 | |||||||||
Depreciation | 48,771 | 14,849 | 33,922 | |||||||||
Total operating expenses: | 4,299,499 | 3,151,477 | 1,148,022 | |||||||||
Operating loss | (2,887,599) | (2,089,695) | (797,904) | |||||||||
Total other income (expense) | (50,744) | (28,470) | (22,274) | |||||||||
Net loss | $ | (2,938,343) | $ | (2,118,165) | $ | (820,178) |
- Prev
- 1
- Next